PHARMIS MEA

PHARMIS MEA – SUPPLIER PROFILE SUMMARY COMPANY OVERVIEW PHARMIS MEA is based in Tunis, Tunisia. The company operates across multiple sectors, including pharmaceutical and health services, manufacturing and maintenance, wholesale and retail, IT and communications, construction and renovation, food and hospitality, agriculture, science and technology, entertainment and media, and other services. This broad industry footprint suggests a diversified business model, though the specific focus and primary revenue drivers are not publicly documented. BUSINESS ACTIVITY The pharmaceutical and health services classification indicates PHARMIS MEA has involvement in the health and wellness sector. However, the full scope of operations—whether the company manufactures products, provides services, distributes goods, or operates in multiple capacities—is not clearly defined in available information. Similarly, the extent of activity in secondary sectors listed is unclear. CREDIBILITY AND CERTIFICATIONS PHARMIS MEA holds a Certified V19 credential, as observed and documented by Reevol. Beyond this certification, information regarding additional quality certifications (such as ISO, GMP, or sector-specific standards), regulatory approvals, or industry memberships is not available. PUBLIC PRESENCE The company has not published a public website, and trade fair participation, export market activity, and digital visibility data are not documented. This limited online footprint may reflect the company's business model, target market focus (potentially regional or B2B-specific), or stage of digital development. Without additional public sources, details on company history, employee size, year of establishment, and specific product or service offerings cannot be verified. MARKET POSITION Reevol has not verified export markets served, specific product categories (HS codes), or the scale of operations. Given the multi-sector classification and Tunis location, PHARMIS MEA may serve regional markets across North Africa or the Middle East, but this is not confirmed. ASSESSMENT GAPS Buyers should note that critical information—including company founding date, organizational size, website presence, product specifications, and certifications beyond V19—is not available through public sources reviewed by Reevol. This profile reflects publicly observable data only. For procurement due diligence, direct contact with PHARMIS MEA is recommended to clarify business scope, product offerings, certifications, production capacity, and compliance with relevant international standards.